Stopping Aspirin a Month After Stent Implant Helps Heart Patients
TUESDAY, April 9, 2024 -- People who ' ve survived a heart attack and have been given a stent may be better off quitting low-dose aspirin a month after the procedure, a new study finds.
The strategy is " beneficial by reducing major and minor bleeding... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 9, 2024 Category: General Medicine Source Type: news
With Ticagrelor, Aspirin May Not Be Needed After PCI for Acute Coronary Syndrome
(MedPage Today) -- ATLANTA -- In select patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndromes who were event-free for 1 month on dual antiplatelet therapy (DAPT), treatment with ticagrelor (Brilinta) alone... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 8, 2024 Category: Cardiology Source Type: news
ACC: Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
MONDAY, April 8, 2024 -- Treatment with ticagrelor alone results in a lower rate of clinically relevant bleeding compared with ticagrelor and aspirin among patients with an acute coronary syndrome who had percutaneous coronary intervention and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2024 Category: Pharmaceuticals Source Type: news
Aspirin for Fatty Liver; Meds for Self-Managed Abortion
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 30, 2024 Category: Cardiology Source Type: news
Aspirin Shows Promise In Treating Common Liver Disease
Daily low dose aspirin may be an effective treatment for a common type of liver disease, according to a new study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 28, 2024 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
Aspirin Cuts Liver Fat in Preliminary MASLD Trial
(MedPage Today) -- Daily low-dose aspirin reduced hepatic fat in patients with noncirrhotic metabolic dysfunction-associated steatotic liver disease (MASLD), a randomized phase II trial showed.
Among the 80 patients in the single-center study... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 20, 2024 Category: Primary Care Source Type: news
An Easy, Effective Solution to Heat Sensitivity in RRMS? An Easy, Effective Solution to Heat Sensitivity in RRMS?
Aspirin and acetaminophen may offer an effective and inexpensive solution to exercise-induced heat sensitivity in relapsing-remitting multiple sclerosis, phase 3 data suggested.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 14, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news
DAPT Maintains Early Neurologic Function in Mild-Moderate Stroke
(MedPage Today) -- In certain patients with mild-to-moderate acute ischemic stroke, dual antiplatelet therapy (DAPT) with aspirin and clopidogrel (Plavix) reduced early neurologic deterioration better than aspirin alone, the Chinese randomized... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 13, 2024 Category: Cardiology Source Type: news
Many Older Americans Pop Daily Aspirin, Even Though It's No Longer Recommended: Poll
FRIDAY, March 8, 2024 -- Lots of seniors are regularly taking low-dose aspirin in hopes of preventing heart attacks and strokes, even though updated guidelines often advise against it.About one in four older adults take aspirin at least three times... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 8, 2024 Category: General Medicine Source Type: news
Is the Faith in Aspirin to Prevent Cardiac Events Warranted?
There’s a disconnect between the millions of people who take aspirin to ward off cardiovascular events and what the evidence shows. (Source: WebMD Health)
Source: WebMD Health - March 6, 2024 Category: Consumer Health News Source Type: news
First over-the-counter birth control pill in US begins shipping to stores
The first will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin. Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply…#manufacturerperrigo #ireland #progestin #progestinpills #usopills #southamerica #africa #verdahicks #gynecologists (Source: Reuters: Health)
Source: Reuters: Health - March 4, 2024 Category: Consumer Health News Source Type: news
Mar 1 2024 This Week in Cardiology Mar 1 2024 This Week in Cardiology
The Western AF meeting, aspirin, cannabis use, LVEF in athletes, and shared decision making before ICD implantation are the topics John Mandrola, MD, discusses in this week ’s podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 1, 2024 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Low-Dose Aspirin Associated With Reduced CRC Risk Low-Dose Aspirin Associated With Reduced CRC Risk
A Norwegian nationwide study revealed that the impact of low-dose aspirin use was greatest for metastatic colorectal cancer and increased with a longer duration of use.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 29, 2024 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news
Apixaban for Cryptogenic Stroke With Atrial Cardiopathy Apixaban for Cryptogenic Stroke With Atrial Cardiopathy
In patients with cryptogenic stroke and evidence of atrial cardiopathy without atrial fibrillation, apixaban did not reduce recurrent stroke vs aspirin in the ARCADIA trial.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 22, 2024 Category: Neurology Tags: Cardiology Source Type: news
ASA: No Drop in Recurrent Stroke Seen With Apixaban After Cryptogenic Stroke
FRIDAY, Feb. 16, 2024 -- For patients with recent cryptogenic stroke and evidence of atrial cardiopathy, the risk for recurrent stroke is not reduced with apixaban versus aspirin, according to a study published online Feb. 7 in the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 16, 2024 Category: Pharmaceuticals Source Type: news
